We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.72B
AUM Growth
-$313M
(-6.2%)
Cap. Flow
-$247M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
13.35%
Holding
1,246
New
455
Increased
271
Reduced
328
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$32.6M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$31.7M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$28.2M |
| 4 |
Targa Resources
TRGP
|
+$25.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$50.8M |
| 2 |
Walt Disney
DIS
|
+$49.8M |
| 3 |
Accenture
ACN
|
+$41.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$35.4M |
| 5 |
Valero Energy
VLO
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAME
801
DELISTED
Rightside Group, Ltd.
NAME
| $386K | 0.01% |
+47,900
| New | +$404K |
|
802
Dawson Geophysical
DWSN
$155M
| $385K | 0.01% |
88,418
+15,313
| +21% | +$52.1K |
|
803
Zumiez
ZUMZ
$320M
| $385K | 0.01% |
+19,348
| New | +$363K |
|
804
Columbia Sportswear
COLM
$3.19B
| $384K | 0.01% |
6,390
-18,050
| -74% | -$991K |
|
|
SQBG
805
DELISTED
Sequential Brands Group, Inc.
SQBG
| $384K | 0.01% |
+1,503
| New | +$391K |
|
|
I
806
DELISTED
INTELSAT S. A.
I
| $384K | 0.01% |
+152,200
| New | +$430K |
|
|
BELFB
807
Bel Fuse Inc Class B
BELFB
$3.88B
| $380K | 0.01% |
+26,016
| New | +$385K |
|
808
DexCom
DXCM
$27.6B
| $377K | 0.01% |
22,200
-5,600
| -20% | -$93.5K |
|
|
XL
809
DELISTED
XL Group Ltd.
XL
| $376K | 0.01% |
10,230
+2,670
| +35% | +$94.9K |
|
|
XOMA
810
DELISTED
Xoma
XOMA
| $374K | 0.01% |
+24,191
| New | +$436K |
|
811
Aspen Aerogels
ASPN
$387M
| $371K | 0.01% |
+82,350
| New | +$373K |
|
812
Standard BioTools
LAB
$326M
| $371K | 0.01% |
+46,000
| New | +$332K |
|
813
Workiva
WK
$2.94B
| $369K | 0.01% |
+31,659
| New | +$417K |
|
814
Fate Therapeutics
FATE
$281M
| $368K | 0.01% |
204,447
+167,194
| +449% | +$344K |
|
|
DSCI
815
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $364K | 0.01% |
117,271
+73,911
| +170% | +$248K |
|
|
CCXI
816
DELISTED
ChemoCentryx, Inc.
CCXI
| $362K | 0.01% |
+145,313
| New | +$529K |
|
817
Kratos Defense & Security Solutions
KTOS
$8.88B
| $357K | 0.01% |
+72,100
| New | +$260K |
|
818
Genpact
G
$5.3B
| $356K | 0.01% |
13,100
-69,148
| -84% | -$1.75M |
|
|
HDNG
819
DELISTED
Hardinge Inc
HDNG
| $356K | 0.01% |
28,542
-6,100
| -18% | -$57.6K |
|
820
Equity Residential
EQR
$25.4B
| $355K | 0.01% |
+4,730
| New | +$354K |
|
821
Bristow Group
VTOL
$1.35B
| $355K | 0.01% |
+18,901
| New | +$351K |
|
|
ININ
822
DELISTED
Interactive Intelligence Group, inc.
ININ
| $355K | 0.01% |
+9,750
| New | +$283K |
|
|
AAIC
823
DELISTED
Arlington Asset Investment Corp.
AAIC
| $354K | 0.01% |
+28,250
| New | +$341K |
|
|
STRZA
824
DELISTED
Starz - Series A
STRZA
| $350K | 0.01% |
+13,300
| New | +$364K |
|
|
LOGM
825
DELISTED
LogMein, Inc.
LOGM
| $349K | 0.01% |
6,910
+1,140
| +20% | +$58.8K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2016 Portfolio in Review
As of Q1 2016, Jacobs Levy Equity Management held 1,246 positions worth $4.72B, down 6.2% from $5.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management withdrew a net $247M in Q1 2016, closing 160 positions and reducing 328 holdings. Its most notable exit was Merck, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Endo International plc worth $16.8M.
- Jacobs Levy Equity Management's largest Q1 2016 buy was Endo International plc: 596,209 shares worth $16.8M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2016, an estimated $32.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2016 reduction was Walt Disney, cutting an estimated $49.8M.
- Jacobs Levy Equity Management fully exited Merck in Q1 2016, selling an estimated $50.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.72B portfolio in Q1 2016.
- Jacobs Levy Equity Management opened 455 new positions and closed 160 in Q1 2016.
- Jacobs Levy Equity Management's portfolio value fell 6.2% quarter-over-quarter to $4.72B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.